Home/Filings/4/0001415889-23-003672
4//SEC Filing

Yuan Qing Sarah 4

Accession 0001415889-23-003672

CIK 0001821323other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 4:36 PM ET

Size

5.5 KB

Accession

0001415889-23-003672

Insider Transaction Report

Form 4
Period: 2023-02-28
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-28+115,000115,000 total
    Exercise: $1.09Exp: 2033-02-27Common Stock (115,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 25% of the underlying shares of common stock on February 28, 2024, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each quarter following such date until the option is fully vested.

Issuer

Sigilon Therapeutics, Inc.

CIK 0001821323

Entity typeother

Related Parties

1
  • filerCIK 0001907487

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:36 PM ET
Size
5.5 KB